Metabolomic Diagnostics have expanded its team by recruiting Paloma Muñiz Ortea and Leslie Brown. Ms. Muñiz Ortea is our R&D Product Development manager. Paloma is trained as an analytical chemist and holds a PhD from the Cork Institute of Technology where she developed analytical methods for the detection of marine toxins using liquid chromatography- mass spectrometry. In 2004 she joined former Fournier Laboratories Ireland (FLI, now Abbvie) where she worked as Development analyst and Senior Analytical Scientist at a later stage. During her time in FLI she was responsible for the leading of the analytical part from development stage to clinical manufacturing and product release to the market. In 2010, she joined NorthStar where she worked as Product Quality Manager and was responsible for ensuring the overall quality of over 30 different products currently on the market under the NorthStar label and other several affiliated labels marketed in the USA and Canada. Paloma has an extensive knowledge in method development as well as in the regulated pharmaceutical manufacturing industry.
Leslie Brown is our Sr. Analyst – Mass Spectrometry. Leslie has over 35 years of hands-on experience in the development, validation and application of analytical methods for determination of small molecules. Within his lifelong career as analytical chemist, he worked over 25 years with LC-MS technology. Following a Medical Technology education in South Africa, Leslie joined the Department of Pharmacology university of Orange Free State, Bloemfontein, South Africa in 1980. Within this department he fulfilled the roles of as Medical Technologist and Chief Medical Technologist till he was urged to join the Clinical Laboratory of the Shandon Clinic, Cork Ireland in 1996. From 1997 till 2015 Leslie worked with Trident, Ireland a specialized bioanalytics laboratory dedicated to rendering specialized LC-MS analysis services for pharmaceutical industry. During his time in Trident Leslie conducted over 400 bioavailability studies using in-house developed LC-MS methods in support of regulatory filings of Pharmaceutical companies. Leslie provides the MDx team with a wealth of experience in the development, validation and application of LC-MS methods.